Search results

Found 245 pages
AUTHOR: Katrina Megget

Results per page

10 20 50 100

Sort by

Relevance Date

4 Sep 2008:

Pharma innovation feels the pinch

Pharma is really starting to feel the pinch of the credit crunch, a new report from Datamonitor says. - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/pharma_innovation_feels_the_pinch_987928

12 Nov 2008:

Pfizer speaks out about counterfeit drugs

Drug Giant Pfizer has publicly warned men about the dangers of buying drugs over the internet. - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/pfizer_speaks_out_about_counterfeit_drugs_986400

5 Apr 2011:

Sanofi-Aventis re-brands generics business as Zentiva

Sanofi-Aventis has created the third largest generics company in Europe after re-branding its generic operations under the name Zentiva. - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/sanofi-aventis_re-brands_generics_business_as_zentiva_979313

7 Oct 2008:

Roche’s MabThera/Rituxan comes up trumps with leukaemia

Roche’s therapeutic antibody MabThera/Rituxan (rituximab) has delayed disease progression in patients with a form of leukaemia, the drug giant says. - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/roches_mabtherarituxan_comes_up_trumps_with_leukaemia_986660

11 Dec 2008:

Sales growth in generics drops

The growth in the global sales of generics has dived to 3.6% in 12 months – down from 11.4% in 2007, a new report says. - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/sales_growth_in_generics_drops_986189

14 Aug 2009:

Support for British NHS on Twitter

Opposition to President Barack Obama’s healthcare reform plans has caused an uproar in the UK with even the British Prime Minister supporting the NHS on Twitter. - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/support_for_british_nhs_on_twitter_983822

10 Sep 2009:

Cervarix recommended for approval by FDA panel

Cervical cancer vaccines have been given a boost in the USA after an advisory panel there recommended approval of GlaxoSmithKline's Cervarix, while Merck & Co's Gardasil got a favourable nod to have its use extended to men - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/cervarix_recommended_for_approval_by_fda_panel_983673

29 Oct 2013:

Teva chief denies resignation rumours

A rumour that Teva’s chief executive Jeremy Levin was stepping down due to a rift in the company’s board has been denied as a “baseless claim”. - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/teva_chief_denies_resignation_rumours_1005925

8 Aug 2014:

Smoking out Ebola with plantibodies

Tobacco could be back in the good books after it was revealed the plant was being used to manufacture the potentially life-saving experimental drug fighting Ebola. - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/smoking_out_ebola_with_plantibodies_1002303

20 Mar 2013:

FDA turns down Pharmaxis cystic fibrosis drug

The US Food and Drug Administration has rejected Pharmaxis’ cystic fibrosis drug Bronchitol because of inadequate trial data. - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/fda_turns_down_pharmaxis_cystic_fibrosis_drug_1004670